abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention relates to novel crystalline modification (R)-DOPC, which can be applied in pharmaceutical industry. Claimed is novel crystalline form of DOPC and method of its obtaining, as well as its application as component in obtaining medications. Claimed method consists in the fact that crystallisation of (R)-DOPC is carried out in aprotic solvent. n EFFECT: claimed crystalline form of DOPC is characterised by improved stability. n 14 cl, 5 ex, 2 tbl, 11 dwg |